In this episode, we’re joined by John Schroder for a deep dive into the evolving landscape of wound care—from the logistical challenges of sourcing and distributing products, to the growing role of skin substitutes (CAMPS), and the impact of policy decisions like LCDs. We trace the journey from product development to real-world patient outcomes, exploring how market forces, innovation, and a commitment to research are reshaping the future of wound care. Whether you're a clinician, policymaker, or industry insider, this conversation breaks down the building blocks of meaningful change. 

Theme music is « Real as it Gets (Dirty Deed) », by Justin G. Marcellus 

Links from the episode: 

Venture Medical:  https://www.venturemedical1.com/ 

Takeda Pharmaceuticals: https://www.takeda.com/en-us/ 

Johnson & Johnson: https://www.jnj.com/ 

Medtronic: https://www.medtronic.com/za-en/index.html 

Smith & Nephew: https://www.smith-nephew.com/en-us 

United Wound Healing: https://www.unitedwoundhealing.com/ 

Timestamps: 

00:00 Intro and origin story 

13:32 Challenges in wound care product distribution nationally 

21:52 Market view and interplay between wound care and diabetes medicine 

31:37 Challenges in sourcing products 

47:38 Future of LCDs 

1:03:13 Commitment to Real World Evidence 

1:07:07 Closing question 

Follow us: 

LinkedIn: https://www.linkedin.com/company/90449662/ 

Facebook: https://www.facebook.com/profile.php?id=100094931934424 

Instagram: https://www.instagram.com/openwoundresearch/ 

Thanks for listening!